ALLMedicine™ Leprosy Center
Research & Reviews 1,292 results
PLoS Neglected Tropical Diseases; Gnimavo RS, Sopoh GE et. al.
Jun 24th, 2022 - In the absence of early treatment, leprosy, a neglected tropical disease, due to Mycobacterium leprae or Hansen Bacillus, causes irreversible grade 2 disability (G2D) numerous factors related to the individual, the community and the health care sy...
PloS One; Spekker O, Tihanyi B et. al.
Jun 24th, 2022 - To give an insight into the different manifestations of leprosy and their biological consequences in the Avar Age of the Hungarian Duna-Tisza Interfluve, two cases from the 7th-century-CE osteoarchaeological series of Kiskundorozsma-Daruhalom-dűlő...
Journal of Global Antimicrobial Resistance; Ahuja M, Singh I et. al.
Jun 19th, 2022 - Purulia is one of the high endemic districts for leprosy in West Bengal [Eastern part of India]. The annual new case detection rate (ANCDR) of leprosy in West Bengal is 6.04/100000 (DGHS 2019-20). Our earlier report has already provided the eviden...
Clinical and Experimental Pharmacology & Physiology; Shi C, Ma S et. al.
Jun 16th, 2022 - Leprosy is an infectious disease caused by non-cultivable bacteria Mycobacterium leprae. Th17 cells play vital roles during pathogenesis of leprosy reactions and IL-23 is involved in Th17 cell differentiation. Although previous studies have report...
Annual Review of Genetics; Gibbs KD, Schott BH et. al.
Jun 14th, 2022 - Since the identification of sickle cell trait as a heritable form of resistance to malaria, candidate gene studies, linkage analysis paired with sequencing, and genome-wide association (GWA) studies have revealed many examples of genetic resistanc...
Drugs 7 results see all →
Clinicaltrials.gov 55 results
Jun 8th, 2022 - The purpose of this study is to assess the efficacy of an 8-week bedaquiline monotherapy regimen in participants with treatment-naive, multibacillary (MB) leprosy.
Jun 6th, 2022 - Given the fact that the investigators are going to provide to healthy people a drug that has not been used before for this indication and which has only been conditionally approved for use in multi-drug resistant tuberculosis, they have first fore...
May 31st, 2022 - Clofazimine is an orphan antibiotic drug that is no longer available through pharmacies in the United States. It is approved for the treatment of Mycobacterium leprae (leprosy) infections. Clofazimine has been used for many years off-label against...
May 25th, 2022 - Study Design: Case-control study Population: 45 patients with active vitiligo and 45 patients with stable vitiligo Inclusion criteria: Age: 18 years old and older Sex: both sexes Exclusion criteria: Other hypopigmented diseases such as pityriasis ...
May 24th, 2022 - Participants (preschool children), because their cognitive ability and anti pressure ability are obviously weaker than adults, most of the children who have this kind of operation and anesthesia stressors will have perioperative anxiety. After eye...
News 78 results
Jun 24th, 2022 - LONDON (Reuters) - GSK and Novartis reinforced commitments on Thursday to tackle neglected tropical diseases, as world leaders and health experts gather in Rwanda to discuss ways to better combat illnesses affecting more than a billion people, mos...
Jun 7th, 2022 - Pandemic. Mental health. Kids in crisis. Doomsday headlines have become commonplace over the past 2 years. The "grownups" are all tired, drained, overwhelmed. So just imagine what it's like for the kids and adolescents. What has happened to them d...
Ruby Gibson, MD, Valerie Shiu, MD et. al.
Apr 26th, 2022 - To the Editor: A 53-year-old Hispanic woman presented to our dermatology clinic for evaluation of an expanding plaque on the right cheek of 2 months’ duration. The patient stated the plaque began as a pimple, which she picked with subsequent sprea.
Amira Shahin, MD, Randa Yousef, MD et. al.
Dec 14th, 2021 - Case Report A 70-year-old man living in Esna, Luxor, Egypt presented to the Department of Rheumatology and Rehabilitation with widespread gangrenous skin lesions associated with ulcers of 2 weeks’ duration. One year prior, the patient had an insid.
Dec 5th, 2020 - The company decided to take a second look at a drug that others had written off for decades. Today, several myeloma patients are living longer lives, and new methods of drug delivery are making therapeutic agents more effective than ever. Lookin...